Retrospective Drug Use Criteria Handbook
- C-1. Introduction
- C-2. Drug Use Compendia
-
C-3. Drug Use Criteria
- C-3.1. Acetylcholinesterase Inhibitors
- C-3.2. Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
- C-3.3. Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs
- C-3.4. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)
- C-3.5. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)
- C-3.6. Angiotensin-Converting Enzyme Inhibitors
- C-3.7. Angiotensin II Receptor Blockers
- C-3.8. Anti-depressants, oral (other)
- C-3.9. Anti-depressants, selective serotonin reuptake inhibitors
- Benzodiazepines (Oral, Nasal, Rectal)
- C-3.10. Anti-diabetic Agents (oral)
- C-3.11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
- C-3.12. Atypical Anti-psychotics (long-acting injectable)
- C-3.13. Atypical Anti-psychotics (oral)
- C-3.15. Complement Inhibitor and Enzyme/Protein Replacement Therapy
- C-3.16. Cyclooxygenase-2 Inhibitors
- C-3.17. Direct Oral Anticoagulants
- C-3.18. Exogenous Insulin Products
- Fentanyl
- Fluoroquinolones (oral)
- Gabapentin
- Glucagon-like Peptide 1 Receptor Agonists
- Histamine H2 - Receptor Antagonists
- Hydrocodone Bitartrate/Hydrocodone Polistirex
- Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors
- Immune Globulins
- Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
- Ketorolac (oral)
- Leukotriene Receptor Antagonists
- Low Molecular - Weight Heparins
- Mecasermin
- Memantine
- Nebulized Bronchodilators
- Nitazoxanide (Alinia)
- Non-sedating Antihistamines
- Non-steroidal anti-inflammatory drugs
- Platelet Aggregation Inhibitors
- Pramlintide
- Promethazine Use In Children Less Than 2 Years of Age
- Proton Pump Inhibitors
- Quetiapine (low dose)
- Rifaximin (Xifaxan)
- Sedative/Hypnotics
- Serotonin 5-HT1B/1D Receptor Agonists
- Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)
- Sickle Cell Disease Products
- Skeletal Muscle Relaxants
- Substance P/Neurokinin1 Receptor Antagonists
- Topical Calcineurin Inhibitors
- Tramadol
- C-4. Revision History